about
Botulinum toxin: bioweapon & magic drugBotulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.Random mutagenesis of BoNT/E Hc nanobody to construct a secondary phage-display library.Ocular adverse effects after facial cosmetic procedures: a review of case reports.Comparison of Two Botulinum Neurotoxin A Injection Patterns with or without the Medial Lower Eyelid in the Treatment of BlepharospasmTreatment of Nystagmus in Brainstem Cavernous Malformation with Botulinum Toxin.Use of Botulinum Neurotoxin in Ophthalmology.Nonsurgical management of diplopia after orbital decompression surgery.Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.Abnormal head position in infantile nystagmus syndrome.Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.Neurologic uses of botulinum neurotoxin type A.Ultrasound-guided injection of botulinum toxin A in the treatment of iliopsoas spasticity.Dry eye syndrome due to botulinum toxin type-A injection: guideline for prevention.Botulinum neurotoxin type A versus punctal plug insertion in the management of dry eye diseaseTransient superior oblique paresis after injection of Botulinum Toxin A for facial rejuvenation.Blepharospasm: long-term treatment with either Botox®, Xeomin® or Dysport®.Botulinum toxin as a postoperative diplopia test - it can also reduce the angle of deviation prior to surgery.Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.Ocular surface changes following botulinum toxin injection for strabismus.Treatment of Blepharospasm/Hemifacial Spasm.Botulinum toxin-A is an effective and safe treatment for chronic migraine.Botulinum toxin treatment in patients up to 3 years of age who have esotropic Duane retraction syndrome.Effect of Hemifacial Spasm on Intraocular Pressure Measurement.Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
P2860
Q34530009-EF68FBFF-BD69-4C5B-B832-4A59F9F94B70Q34593652-D19C90F5-BA9E-43A8-B28B-305B72929445Q35157493-D4DA67C1-F5C7-40B8-82BD-D10F0D0D331FQ35581430-1B2476C1-BE05-43BC-8915-135995BE98D9Q36537765-9C839F91-867A-4549-8FF1-7D8DDC4FAD7CQ36854972-DFAE0BF5-CC0C-4814-B63D-6E6650D0F5D2Q37525827-053248D2-8924-42CD-AC46-D1558BAC961CQ38045887-22E8450E-245C-4E63-97A1-430539F2C7FAQ38120775-2CF853B7-857E-48E3-87A3-50BB32C1AEDAQ38188562-7A81447E-E22D-4C50-A748-4C353F104D8BQ39300250-6E70488D-1FB8-41C4-9687-DA57B666E261Q42086848-B09D1100-2BE4-4251-8F7B-C1C95B9675D1Q42095025-47F5BED2-081A-46BB-9FBF-2165ECBAB262Q42098298-F545663D-2188-4A0A-A9DF-B5F185E9E4F4Q42793888-3B0C76AF-62D5-4A99-88D6-719A12FE2907Q43060411-63660D00-844D-4CA8-91A5-97A9D50C2D6AQ43697542-003E124F-1761-429A-A279-558F5F02F126Q43711448-29B71789-54CD-4EC1-8822-8D264C567F86Q47548529-F1BB8289-4A88-409D-B834-D37EA361B166Q47836947-351F6D30-711D-4CF8-97AD-21B823A71433Q47921509-D0195281-BBB2-4B18-9134-E4B8D5F4A202Q47985193-5D39CF9D-064D-4F08-9600-E0B9EE60E8F2Q48974189-1511663E-3F0C-465E-81CE-C1D119EA847DQ55025550-29AD13CE-0B51-48F9-9136-3B1BD35D77C4Q55068706-3C1D079F-E313-4196-B83B-5EE5EC8C1DF1
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Botulinum toxin in ophthalmology.
@ast
Botulinum toxin in ophthalmology.
@en
type
label
Botulinum toxin in ophthalmology.
@ast
Botulinum toxin in ophthalmology.
@en
prefLabel
Botulinum toxin in ophthalmology.
@ast
Botulinum toxin in ophthalmology.
@en
P1476
Botulinum toxin in ophthalmology.
@en
P2093
Amy M Fowler
Jonathan J Dutton
P356
10.1016/J.SURVOPHTHAL.2006.10.003
P577
2007-01-01T00:00:00Z